Cinctive Capital Management LP Buys New Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Cinctive Capital Management LP purchased a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 139,305 shares of the company’s stock, valued at approximately $2,723,000. Cinctive Capital Management LP owned 0.12% of Privia Health Group as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after buying an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. acquired a new position in shares of Privia Health Group during the fourth quarter valued at about $51,000. Quarry LP increased its position in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after acquiring an additional 2,533 shares in the last quarter. Finally, Neo Ivy Capital Management acquired a new stake in shares of Privia Health Group in the 3rd quarter worth about $66,000. Institutional investors own 94.48% of the company’s stock.

Analyst Upgrades and Downgrades

PRVA has been the subject of a number of analyst reports. JMP Securities set a $29.00 price target on Privia Health Group in a research note on Friday, February 28th. Canaccord Genuity Group upped their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Stephens restated an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price for the company. Finally, Needham & Company LLC reissued a “buy” rating and set a $30.00 price target on shares of Privia Health Group in a research report on Friday, March 21st. One research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $26.67.

Privia Health Group Stock Down 2.3 %

NASDAQ PRVA opened at $22.36 on Thursday. The company has a market cap of $2.69 billion, a PE ratio of 223.62, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. The firm’s 50-day simple moving average is $23.80 and its two-hundred day simple moving average is $21.26. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.